Therapeutic Opportunities in Overcoming Premature Termination Codons in Epidermolysis Bullosa via Translational Readthrough is a research paper published in Cells (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Epidermolysis Bullosa Research Partnership and Epidermolysis Bullosa Medical Research Foundation
Grant: NIH RO1 AR47981
Epidermolysis Bullosa Research Partnership and Epidermolysis Bullosa Medical Research Foundation
Grant: RC4AR060535
Epidermolysis Bullosa Research Partnership and Epidermolysis Bullosa Medical Research Foundation
Grant: RO1 AR33625
Epidermolysis Bullosa Research Partnership and Epidermolysis Bullosa Medical Research Foundation
Grant: W81XWH-1810558
NIAMS NIH HHS
Grant: R01 AR033625
NIH HHS
Grant: RO1 AR47981
NIAMS NIH HHS
Grant: R01 AR047981
National Institutes of Health
Grant: 5R01AR047981-07
Strategies Towards Gene Therapy for Dystrophic Epidermolysis Bullosa
National Institutes of Health
Grant: 1RC4AR060535-01
Protein Therapy for Recessive Dystrophic Epidermolysis Bullosa
National Institutes of Health
Grant: 5R01AR033625-11
PURIFICATION OF EPIDERMOLYSIS BULLOSA ANTIGEN
FWCI
1.19
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords